Immuneering (IMRX) Assets (2020 - 2026)
Immuneering (IMRX) posted quarterly Assets of $214.8 million for Q1 2026, up 323.84% year-over-year from $50.7 million in Q1 2025, and down 7.4% quarter-over-quarter from $232.0 million in Q4 2025.
Immuneering (IMRX) Assets (2020 - 2026) Analysis & Trends
Immuneering's Assets history runs 7 years deep, the most recent figure standing at $214.8 million for Q1 2026.
- In Q1 2026, Assets rose 323.84% year-over-year to $214.8 million; the TTM figure through Mar 2026 stood at $214.8 million (up 323.84% YoY), while the FY2025 annual figure was $232.0 million, up 340.08% from the prior year.
- Assets for Q1 2026 stood at $214.8 million, down from $232.0 million in the prior quarter.
- The five-year high for Assets was $241.1 million in Q3 2025, with the low at $40.1 million in Q2 2025.
- The 5-year median for Assets is $113.9 million (2023), against an average of $121.4 million.
- The sharpest annual moves came in 2024 and 2025: Assets tumbled 48.61% in 2024, then soared 340.08% in 2025.
- Immuneering's Assets stood at $122.4 million in 2022, then declined by 16.17% to $102.6 million in 2023, then sank by 48.61% to $52.7 million in 2024, then jumped by 340.08% to $232.0 million in 2025, then retreated by 7.4% to $214.8 million in 2026.
- Business Quant data shows IMRX's Assets at $214.8 million in Q1 2026, $232.0 million in Q4 2025, and $241.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Immuneering | 327.37 Mn | 327.37 Mn | - | 202.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 202.06 Mn |
| Mar 31, 2026 | 214.81 Mn |
| Dec 31, 2025 | 231.99 Mn |
| Sep 30, 2025 | 241.06 Mn |
| Jun 30, 2025 | 40.06 Mn |
| Mar 31, 2025 | 50.68 Mn |
| Dec 31, 2024 | 52.71 Mn |
| Sep 30, 2024 | 68.56 Mn |
| Jun 30, 2024 | 77.09 Mn |
| Mar 31, 2024 | 87.98 Mn |
| Dec 31, 2023 | 102.58 Mn |
| Sep 30, 2023 | 113.88 Mn |
| Jun 30, 2023 | 124.90 Mn |
| Mar 31, 2023 | 107.70 Mn |
| Dec 31, 2022 | 122.37 Mn |
| Sep 30, 2022 | 133.69 Mn |
| Jun 30, 2022 | 142.05 Mn |
| Mar 31, 2022 | 152.45 Mn |
| Dec 31, 2021 | 166.70 Mn |
| Sep 30, 2021 | 164.04 Mn |